Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioreactor Controls-I01:28

Bioreactor Controls-I

28
Maintaining optimal conditions within fermenters is essential for maximizing microbial productivity and ensuring process efficiency. This lesson focuses on key parameters—temperature, foam, pH, carbon dioxide, oxygen, and pressure—and their precise measurement and control strategies in fermentation systems.Temperature ControlTemperature regulation is critical due to the exothermic nature of many fermentation processes. In small laboratory fermenters, temperature is commonly...
28
Upstream Processing01:27

Upstream Processing

36
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
36
Bioreactor Controls-III01:22

Bioreactor Controls-III

24
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
24
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

348
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
348
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

1.3K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

522
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
522

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

O-GlcNAcylated YTHDF2 promotes bladder cancer progression by regulating the tumor suppressor gene <i>PER1</i> via m<sup>6</sup>A modification.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2025
Same author

OTUD1 downregulates PD-L1 expression by deubiquitinating STAT3 and promotes the immune response in ccRCC.

Cellular oncology (Dordrecht, Netherlands)·2025
Same author

Analytical control strategy for biologics. Part I: Foundations.

Journal of pharmaceutical sciences·2025
Same author

A telomere-to-telomere genome assembly coupled with multi-omic data provides insights into the evolution of hexaploid bread wheat.

Nature genetics·2025
Same author

CircST6GALNAC6 Inhibits Glycolysis of Bladder Cancer by Regulating PRKN/HK1 Signaling Pathway.

Molecular carcinogenesis·2025
Same author

Quality risk management and data integrity in R&D laboratories supporting CMC lifecycle of biological products.

Journal of pharmaceutical sciences·2024

相关实验视频

Updated: Mar 26, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.3K

生物制剂的分析控制策略. 第二部分:发展和实施路线图

Krishnan Sampathkumar1, Brent S Kendrick2, John P Gabrielson3

  • 1SSK Biosolutions LLC, North Potomac, MD 20878; Currently at Invetx, Inc. by Dechra, Natick, MA 01760.

Journal of pharmaceutical sciences
|May 16, 2025
PubMed
概括
此摘要是机器生成的。

本文为开发生物疗法分析控制策略提供了一份路线图. 它详细介绍了从临床前开发到商业化为综合产品控制的相应阶段的方法.

关键词:
生物制剂 生物制剂 生物制剂在CMC的路线图中.在QbD中,它是QbD.质量目标产品简介质量目标产品简介分析方法开发 分析方法开发分析方法验证分析方法验证控制战略 控制战略 控制战略配方的强度 配方的强度方法资格认证方法资格认证一个单克隆抗体.

更多相关视频

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.5K

相关实验视频

Last Updated: Mar 26, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.3K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.5K

科学领域:

  • 生物制药开发 生物制药开发
  • 分析化学 分析化学
  • 监管科学 监管科学

背景情况:

  • 生物疗法具有多样化的分子形状,需要强大的控制策略.
  • 现有的指导侧重于具体研究,缺乏全面的分析控制战略框架.
  • 本文是系列文章的第二部分,基于分析控制策略的基本概念.

研究的目的:

  • 提出一个精简的,适合阶段的路线图,用于开发和实施治疗生物制剂的分析控制策略.
  • 引导分析控制策略在整个产品生命周期的整合,从临床前到商业化.
  • 解决针对生物制剂综合分析控制战略开发的具体指导的缺口.

主要方法:

  • 审查和综合现有监管指南 (ICH,FDA,EMA) 和科学文献.
  • 为实施分析控制战略制定与生命周期一致的路线图.
  • 专注于关键要素:质量目标产品配置文件 (QTPP),流程开发,分析方法开发,资格,验证和验证.

主要成果:

  • 一个实用的路线图,用于在不同生物制品模式中开发分析控制策略.
  • 强调从开发早期阶段到商业上市时整合分析控制.
  • 在整个产品生命周期中调整技术和监管要求.

结论:

  • 一个明确的分析控制策略对于治疗生物制剂的成功开发和商业化至关重要.
  • 拟议的路线图为分析控制提供了相应阶段的综合方法.
  • 实施这一战略可确保各种生物制品的产品质量和监管合规性.